The CTS newsletters are available in PDF and HTML formats. For optimal graphics performance use the freely available
Adobe Acrobat Reader to view PDF documents.
| Year |
Issue |
Topics |
Format |
| 2024 |
1 |
New structure of the CTS coordination
|
PDF | HTML |
|
2 |
Comparative global analysis of kidney transplant outcomes with regard to World Bank Group country classification by income level
|
PDF | HTML |
|
3 |
Comparative analysis of kidney transplant outcomes among high income countries
|
PDF | HTML |
|
4 |
Influence of steroid type and dosage on the incidence of de novo osteoporosis in kidney transplant recipients
(current, password-protected, CTS participants only)
|
PDF | HTML |
| 2023 |
1 |
Impact of HDL and LDL cholesterol on kidney graft rejection and survival
|
PDF | HTML |
|
2 |
Posttransplant blood pressure and kidney graft survival in pediatric patients
|
PDF | HTML |
|
3 |
Recipient sex- and age-related differences in graft failure and mortality after kidney transplantation
|
PDF | HTML |
|
4 |
Comparison of mortality and cause of death in kidney, liver and heart transplantation
|
PDF | HTML |
| 2022 |
1 |
Impact of SARS-CoV-2 infection on kidney transplant patient survival
|
PDF | HTML |
|
2 |
Predictors of graft failure in retransplants
|
PDF | HTML |
|
3 |
Impact and predictors of delayed graft function in kidney transplantation
|
PDF | HTML |
|
4 |
Joint analysis of pretransplant antibodies detected by CDC and SAB
|
PDF | HTML |
| 2021 |
1 |
CTS Covid-19 Projects. Impact of cold ischemia time and HLA matching on ECD kidneys
|
PDF | HTML |
|
2 |
Epitope versus traditional HLA matching
|
PDF | HTML |
|
3 |
Impact of HLA match on kidneys from related living donors
|
PDF | HTML |
|
4 |
Mortality of kidney transplant patients compared to normal population
|
PDF | HTML |
| 2020 |
1 |
Changes in the influence of donor age
|
PDF | HTML |
|
2 |
Current impact of pre- and post-transplant DSA
|
PDF | HTML |
|
3 |
Original disease and influence of donor age and cold ischemia time in liver transplantation
|
PDF | HTML |
|
4 |
Influence of donor age in heart transplantation
|
PDF | HTML |
| 2019 |
1 |
Pulse pressure and outcome in kidney transplantation
|
PDF | HTML |
|
2 |
Late intra-patient tacrolimus trough level variability
|
PDF | HTML |
|
3 |
Improvement of outcome in living donor kidney transplantation
|
PDF | HTML |
|
4 |
Cold ischemia times, HLA matching and graft survival
|
PDF | HTML |
| 2018 |
1 |
Time on dialysis and graft survival
|
PDF | HTML |
|
2 |
Maintenance immunosuppression with calcineurin inhibitors
|
PDF | HTML |
|
3 |
Influence on graft survival of acute rejection, DGF and HLA antibodies
|
PDF | HTML |
|
4 |
Incidence of post-transplant cancer in kidney graft recipients with pre-transplant malignancies
|
PDF | HTML |
| 2017 |
1 |
HLA match and graft survival, interactive PDF forms |
PDF | HTML |
| |
2 |
Comparison living vs. deceased donor transplants |
PDF | HTML |
| |
3 |
Pediatric liver transplantation |
PDF | HTML |
| |
4 |
Influence of blood pressure and calcineurin inhibitors on kidney function |
PDF | HTML |
| 2016 |
1 |
Recipient and donor age in pediatric patients |
PDF | HTML |
| |
2 |
mTOR inhibitors and cancer |
PDF | HTML |
| |
3 |
Antibody induction, DSA and sCD30 |
PDF | HTML |
| |
4 |
Kidneys from elderly donors, crossmatch in liver transplantation |
PDF | HTML |
| 2015 |
1 |
Steroid dosage and posttransplant cataract |
PDF | HTML |
| |
2 |
Current impact of preformed antibodies |
PDF | HTML |
| |
3 |
Impact of smoking, center-specific analysis |
PDF | HTML |
| |
4 |
Changes in the recipient profile |
PDF | HTML |
| 2014 |
1 |
Tacrolimus trough levels and kidney graft survival |
PDF | HTML |
| |
2 |
Website access frequencies CTS newsletters |
PDF | HTML |
| |
3 |
Age-adjusted improvement of kidney graft survival |
PDF | HTML |
| |
4 |
CMV prophylaxis and cardiovascular death or death from infection |
PDF | HTML |
| 2013 |
1 |
Kidney graft outcome, recipient-donor age combinations |
PDF | HTML |
| |
2 |
HLA match and death due to infection in heart and liver transplantation |
PDF | HTML |
| |
3 |
10-year analysis of prospective steroid withdrawal study |
PDF | HTML |
| |
4 |
Steroid treatment and death due to infection in heart and lung transplant recipients |
PDF | HTML |
| 2012 |
1 |
Long-term outcomes: serum creatinine, cataract, osteoporosis |
PDF | HTML |
| |
2 |
Death with a functioning graft |
PDF | HTML |
| |
3 |
HLA match and death due to infection, cardiovascular disease, cancer |
PDF | HTML |
| |
4 |
Age and kidney graft survival and function |
PDF | HTML |
| 2011 |
1 |
Recipient age, rejection and HLA matching |
PDF | HTML |
| |
2 |
Cardiovascular death and death from infection |
PDF | HTML |
| |
3 |
Respiratory tract cancer in kidney recipients |
PDF | HTML |
| |
4 |
Statin treatment and death with a functioning kidney graft |
PDF | HTML |
| 2010 |
1 |
Ischemia time and HLA matching |
PDF | HTML |
| |
2 |
HLA matching and incidence of posttransplant lymphoma |
PDF | HTML |
| |
3 |
Standardized tumor incidence rates |
PDF | HTML |
| |
4 |
HLA and lung transplantation |
PDF | HTML |
| 2009 |
1 |
Posttranspant hypercholesteremia and de-novo diabetes |
PDF | HTML |
| |
2 |
Outcome comparison with different immunosuppressive regimens |
PDF | HTML |
| |
3 |
Immunosuppressive regimens and pediatric kidney transplants |
PDF | HTML |
| |
4 |
EBV and lymphoma |
PDF | HTML |
| 2008 |
1 |
Time of rejection and long-term graft survival |
PDF | HTML |
| |
2 |
Acute rejection and graft outcome in heart, lung, liver, pancreas transplantation |
PDF | HTML |
| |
3 |
Preformed antibodies against HLA class I and II |
PDF | HTML |
| |
4 |
Decrease or withdrawal of immunosuppression, HY gender effect |
PDF | HTML |
| 2007 |
1 |
Completeness of follow up. HLA matching and short ischemia |
PDF | HTML |
| |
2 |
Crossmatch analysis |
PDF | HTML |
| |
3 |
Non-heartbeating donors, hypertensive donors, other marginal donors |
PDF | HTML |
| |
4 |
Blood transfusions and antibodies against HLA and MICA |
PDF | HTML |
| 2006 |
1 |
Influence of center size and early success rate on long-term outcome of kidney, heart and liver transplants |
PDF | HTML |
| |
2 |
Antibody induction and incidence of non-Hodgkin lymphoma |
PDF | HTML |
| |
3 |
Lymphoma and antibody induction non-renal transplants. Overall CTS statistics |
PDF | HTML |
| |
4 |
ACEI/ARB treatment and long-term kidney graft survival |
PDF | HTML |
| 2005 |
1 |
Donor age effect. Steroid withdrawal study |
PDF | HTML |
| |
2 |
ABO incompatible kidney transplants |
PDF | HTML |
| |
3 |
Preoperative cyclosporine |
PDF | HTML |
| |
4 |
Successful control of posttransplant hypertension and kidney graft survival |
PDF | HTML |
| 2004 |
1 |
Quality of HLA typing, HLA matching in kidney transplantation |
PDF | HTML |
| |
2 |
Unrelated living donors, short ischemia, HLA matching |
PDF | HTML |
| |
3 |
Hypertension and ACE inhibitors |
PDF | HTML |
| |
4 |
Related donor and split liver transplants |
PDF | HTML |
| 2003 |
1 |
TaXi expansion, incidence of rectal cancer |
PDF | HTML |
| |
2 |
Influence of serum cholesterol in kidney and heart transplantation |
PDF | HTML |
| |
3 |
Pretransplant sCD30 and HLA matching |
PDF | HTML |
| |
4 |
Posttransplant cancer |
PDF | HTML |
| 2002 |
1 |
Ischemic preservation time, anti-HLA antibodies |
PDF | HTML |
| |
2 |
Analysis of sCD30 in kidney transplantation. Announcement of prospective sCD30 and anti-HLA antibody study |
PDF | HTML |
| |
3 |
Combined kidney+liver and kidney+heart transplants |
PDF | HTML |
| 2001 |
1 |
Software development. Generic cyclosporine |
PDF | HTML |
| |
2 |
Cause of donor death |
PDF | HTML |
|
3 |
New database TaXi. HLA matching and modern immunosuppression |
PDF | HTML |
| |
4 |
Anti-HLA class I and class II antibodies |
PDF | HTML |
| 2000 |
1 |
DNA typing project. Pretransplant risk categories |
PDF | HTML |
| |
2 |
Improved transplant survival |
PDF | HTML |
| |
3 |
Center-specific analysis |
PDF | HTML |
| |
4 |
Update steroid withdrawal study, 4-year results |
PDF | HTML |
| 1999 |
1 |
Prospective Steroid Withdrawal Study |
PDF | HTML |
| |
2 |
Sibling Haplotype Project. Steroid Withdrawal Project |
PDF | HTML |
| |
3 |
Role of IgA-anti-Fab Antibodies |
PDF | HTML |
| |
4 |
CTS Website Update. Pretransplant Risk Assessment (Graft and patient survival) |
PDF | HTML |
| 1998 |
1 |
Blood Pressure and Graft Survival |
PDF | HTML |
| |
2 |
DNA Typing Project (A+B locus). Blood Pressure and Heart Transplants |
PDF | HTML |
| |
3 |
CYA Dosage and Graft Outcome. Steroid-free Maintenance |
PDF | HTML |
| |
4 |
Pretransplant CMV Status. CMV Prophylaxis |
PDF | HTML
|
| 1997 |
1 |
Posttransplant Malignancies |
PDF | HTML |
| |
2 |
HLA-DR+DP Broad/Split Specificity Matches. Importance of DNA Typing |
PDF | HTML |
| |
3 |
Randomized Transfusion Study |
PDF | HTML |
| |
4 |
HIT Project |
PDF | HTML |
| 1996 |
1 |
HLA Matching in Non-renal Transplantation |
HTML |
| |
2 |
HLA matching in Heart Transplantation. Repeat Heart Transplants |
HTML |
| |
3 |
Molecular Typing for HLA-DRB. Recipient Age in Renal Transplantation |
PDF | HTML |
| |
4 |
Cold Ischemic Preservation Times. HLA Matching and Graft Survival with Short Cold Ischemia |
PDF | HTML |
| |
5 |
Early Immunological Rejection and Chronic Graft Loss. Taboo Mismatches |
PDF | HTML |
| 1995 |
1 |
"Permissible" HLA mismatches |
HTML |
| |
2 |
HIT Trial for highly immunized patients |
HTML |
| |
3 |
"Graft Adaption" |
HTML |
| |
4 |
Induction Treatment with OKT3 |
HTML |
| 1994 |
1 |
Patient Survival after Diagnosis of Posttransplant Lymphomas |
HTML |
| |
2 |
HLA Matching in Heart Transplantation. Influence of Donor Age |
HTML |
| |
3 |
Maintenance Immunosuppression in Renal Transplant Recipients |
HTML |
| |
4 |
Steroid Withdrawal Project |
HTML |
| 1993 |
1 |
HLA Compatibility in Liver Transplantation |
HTML |
| |
2 |
Kidney Preservation Methods |
HTML |
| |
3 |
Impact of AB0 Compatibility/Incompatibility on Graft Survival |
HTML |
| |
4 |
XCOMB Allocation Method |
HTML |
| |
5 |
Posttransplant non-Hodgkin's Lymphomas |
HTML |
| 1992 |
1 |
Donor Age in Liver and Pancreas Transplantation. Relevance of HLA-A and -B Antigen Splits |
HTML |
| |
2 |
10th CTS Anniversary Symposium |
HTML |
| |
3 |
Discrepancies between Serological and DNA Typing |
HTML |
| |
4 |
Graft and Patient Survival for "Good", "Mediocre" or "Poor" Risk Patients |
HTML |
| 1991 |
1 |
Kidney Transplants from Live Unrelated Donors |
HTML |
| |
2 |
Analysis of Pancreas Transplants |
HTML |
| |
3 |
CMV Status of Transplant Recipients and Donors |
HTML |
| |
4 |
DNA-RFLP Project |
HTML |
| |
5 |
Donor Age in Kidney and Heart Transplantation |
HTML |
| 1990 |
1 |
Evolution of Kidney and Heart Transplant Studies |
HTML |
| |
2 |
Transplant Results for Different Diseases |
HTML |
| |
3 |
Sequential Immunosuppression for Kidney and Heart Transplantation |
HTML |
| |
4 |
Sequential Immunosuppression with OKT3 rather than ATG/ALG Induction |
HTML |
| |
5 |
Yearly Success Rates for Kidney, Heart, Liver and Pancreas Transplants |
HTML |
| |
6 |
Estimation of Long-Term Kidney Graft Survival Rates |
HTML |
| 1989 |
1 |
HLA Matching in Second Transplants |
HTML |
| |
2 |
Sequential Immunosuppression |
HTML |
| |
3 |
Role of Remote Positive Crossmatch |
HTML |
| |
4 |
Survival of father to child as compared to mother to child transplants |
HTML |
| |
5 |
Heart and kidney transplants and the alleged nephrotoxic effect of Cyclosporine |
HTML |
| |
6 |
Pancreas transplants |
HTML |
| |
7 |
Matching for HLA split antigens |
HTML |
| 1988 |
1 |
Influence of recipient/donor age |
HTML |
| |
2 |
59 verified AB0 incompatible cadaver transplants |
HTML |
| |
3 |
Pretransplant transfusions |
HTML |
| |
4 |
Importance of HLA antigen "splits" |
HTML |
| |
5 |
Preliminary analysis of immunosuppression questionnaires |
HTML |
| |
6 |
Influence of HLA matching with or without Cyclosporine |
HTML |
| 1987 |
1 |
HLA-B+DR mismatches in first cadaver transplants |
HTML |
| |
2 |
Influence of recipient age |
HTML |
| |
3 |
Age and patient survival in different disease categories |
HTML |
| |
4 |
Explanation of clinical grades |
HTML |
| |
5 |
Type and time of dialysis |
HTML |
| |
6 |
Type and time of dialysis. Influence of HLA-B+DR mismatches |
HTML |
| |
7 |
First and second transplants with Cyclosporine. Importance of good quality HLA typing |
HTML |
| 1986 |
1 |
Comparison cadaver transplants with or without Cyclosporine |
HTML |
| |
2 |
Recipient/Donor age, with or without Cyclosporine |
HTML |
| |
3 |
Preformed lymphocytotoxic antibodies |
HTML |
| |
4 |
High level antibodies and HLA matching |
HTML |
| |
5 |
Retransplants |
HTML |
| |
6 |
Pretransplant transfusions |
HTML |
| |
7 |
Influence of HLA-B+DR matching on Cyclosporine-treated transplants |
HTML |
| |
8 |
Patient and graft survival: Cyclosporine, original disease, risk factors |
HTML |
| 1985 |
1 |
Effect of HLA-A, -B and -DR Mismatches on graft survival |
HTML |
| |
2 |
Effect of Cyclosporine on graft survival |
HTML |
| |
3 |
Effect of Cyclosporine and HLA-B, -DR mismatches on graft survival |
HTML |
| |
4 |
Survival rates for "good", "moderate" or "poor" Risk patients in Europe, North America and other continents |
HTML |
| |
5 |
Comparison of Cyclosporine versus conventional immunosuppression in children |
HTML |
| |
6 |
Introduction of CTS sera sets. Results of crossmatch analysis |
HTML |
| 1984 |
1 |
Cross match analysis correlation of HLA matching with graft outcome |
HTML |
| |
2 |
Analysis of extended red cell antigen data, the complement of Bf markers and whether or not donor was transfused |
HTML |
| |
3 |
Survival in patients with or without CyA |
HTML |
| |
4 |
Influence of ischemia times on graft survival |
HTML |
| |
5 |
Differential effect of HLA matching with ischemia times |
HTML |
| 1983 |
1 |
Transplant results in relation to preformed lymphocytotoxic antibodies |
HTML |
| |
2 |
Analysis of different immunosuppressive protocols. DR6 effect on graft survival |
HTML |
| |
3 |
Combined analysis of HLA-B plus HLA-DR on graft survival |
HTML |
| |
4 |
Matching for HLA-A, -B and -DR |
HTML |